Page last updated: 2024-08-16

propofol and mk-0524

propofol has been researched along with mk-0524 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barter, Z; Gibson, CR; Lai, E; Lu, P; Maciolek, C; Nicoll-Griffith, DA; Rowland-Yeo, K; Stroh, M; Wudarski, C	1

Trials

1 trial(s) available for propofol and mk-0524

Article	Year
Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:12 Topics: Administration, Intravenous; Adult; Estradiol; Female; Glucuronides; Glucuronosyltransferase; Humans; Indoles; Isoenzymes; Kidney; Kinetics; Male; Metabolic Clearance Rate; Microsomes, Liver; Propofol; Recombinant Proteins; Substrate Specificity; UDP-Glucuronosyltransferase 1A9; Young Adult; Zidovudine	2013

Article

Year

Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans.

Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:12

Topics: Administration, Intravenous; Adult; Estradiol; Female; Glucuronides; Glucuronosyltransferase; Humans; Indoles; Isoenzymes; Kidney; Kinetics; Male; Metabolic Clearance Rate; Microsomes, Liver; Propofol; Recombinant Proteins; Substrate Specificity; UDP-Glucuronosyltransferase 1A9; Young Adult; Zidovudine

2013